Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Experimental & Molecular Medicine|August 13, 2021
Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasionJingyi Zhao, Bingyan Li, Yongxia Ren, et al.
BMC Cancer|June 9, 2018
p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cellsXue Hou, Run Gong, Jianhua Zhan, et al.
The Oncologist|January 14, 2018
Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-AnalysisZhonghan Zhang, Yaxiong Zhang, Gang Chen, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 22, 2018
Evaluating a framework for tuberculosis screening among healthcare workers in clinical settings, Inner Mongolia, ChinaShiming Cheng, Deanna Tollefson, Guangxue He, et al.
Frontiers in Oncology|May 9, 2022
Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer PatientsChao Fang, Wenfeng Fang, Liqin Xu, et al.
Oncotarget|March 3, 2016
Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network meta-analysisYaxiong Zhang, Jin Sheng, Yunpeng Yang, et al.
Plos One|May 22, 2015
The Prevalence and Incidence of Latent Tuberculosis Infection and Its Associated Factors among Village Doctors in ChinaGuangxue He, Yuan Li, Fei Zhao, et al.
Cancer Cell|April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trialYuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Pageof 9